Corona Virus Infection, Flu Vaccine, Immunity
Conditions
Brief summary
The purpose of this study is to measure immunity to the flu vaccine over time in patients who have had COVID-19 and may have other medical conditions including obesity, type 2 diabetes, chronic fatigue, or long-term COVID-19 symptoms. Adults and children (age 9 to 64) who had been diagnosed with COVID-19 as well as controls without COVID-19 will be invited to participate in this study.
Interventions
BIOLOGICALFlu shot
All participants will receive a single shot of the flu vaccine
Sponsors
Stanford University
National Institute of Allergy and Infectious Diseases (NIAID)
Study design
Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
9 Years to 64 Years
Healthy volunteers
Yes
Inclusion criteria
* Age 9 through 64 years * Diagnosed with COVID-19 at least 2 months prior enrollment * Patients with or without obesity, diabetes, chronic fatigue and/or long term COVID-19 symptoms * Patients without COVID-19 diagnosis for controls
Exclusion criteria
* Received the influenza vaccine less than 4 months ago * Pregnant or lactating * Patients with special risks attendant to venipuncture * Use of immunomodulatory medications that may impact vaccine immune response per clinician's judgment * Contraindication to the flu vaccine * Immunodeficiency or autoimmune disease that may impact vaccine immune responses per clinician's judgement
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Testing immunity to the flu vaccine over time | 1 week |
Countries
United States
Contacts
CONTACTSNP Center Inquiry
PRINCIPAL_INVESTIGATORSayantani Sindher, MD
Stanford University
Outcome results
None listed